Monthly Archives: July 2016

Coronary Artery Disease -Pipeline Insights- 2016

Coronary Artery Disease

SUMMARY

Coronary Artery Disease (CAD)-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Coronary Artery Disease (CAD). The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsights Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Coronary Artery Disease (CAD). DelveInsights Report also assesses the Coronary Artery Disease (CAD) therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Scope

The report provides competitivepipeline landscape of Coronary Artery Disease (CAD)
The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
Coverage of the Coronary Artery Disease (CAD) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
The report reviews key players involved in the therapeutics development for Coronary Artery Disease (CAD) and also provide company profiling
The report also gives the information of dormant and discontinued pipeline projects
Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type.

Browse full report @ http://www.aarkstore.com/pharmaceuticals-healthcare/178947/coronary-artery-disease-cad-pipeline-insights-2016

Reasons to buy

Complete Pipeline intelligence and complete understanding over therapeutics development for Coronary Artery Disease (CAD)
Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
Devise corrective measures for pipeline projects by understanding Coronary Artery Disease (CAD) pipeline depth and focus of Indication therapeutics
Developing strategic initiatives to support your drug development activities.
Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Gaining a Full Picture of the Competitive Landscape for Evidencebased Decisions

Best Selling Reports :

Global Coronary Stent Devices Industry 2016 Market Research Report

PharmaPoint: Peripheral Artery Disease – Global Drug Forecast and Market Analysis to 2024

Advertisements

Custom Market Research- Meeting Client Needs with Complete Solutions

Custom research is research, which is made for the needs of the client, rather than a pre-made report. We are working with some of the largest marketing research agencies globally. We are partners with leading event organizers world-wide to market their conferences, events and seminar meetings and promote them through our extensive customer database and proactive marketing campaigns. Aarkstore partners with The Business Research Company, Global Data, Markets and Markets and many more for customized research.We are an interactive platform that provides the user with unlimited and immediate access to invaluable market data from across more than 100 industries and around 90 countries.

Clients can get all their business queries answered with support from custom market research company, which allows dedicated expertise in report making suiting to requirements. The project details, goals, company, market dynamics are well analyzed to arrive at perfect solutions.

 

Help Users Find Answer to Key Questions

Aarkstore partners with Global Research and Data Services for Online Databases. We benchmark B2B user potential according to commercial, educational, or technical needs. Identifying top USPs for critical ranking of business is what we are looking for via business research reports, which are composed with statistics, financial data, company profiles, audience mapping, geographical details, and more.

  • What is current market size for product of interest different countries and globally?
  • How are the markets divisional into several product segments?
  • How is the whole market and product segments growing?
  • How is the market predicted for development in future?
  • What is the potential of market between product criteria and countries?

Major Deliverables and Competition Study

The success of our clients builds on us understanding and meeting their project requirements in the best way to reach faster, yet credible consumer research. We offer compelling business cases based on accurate estimations, entry strategies, dynamics, segmentation, and apt positioning in the industry. Our business research reports are cut out to grasp a high percentage quality and take on commitments seriously.

  • We conceptualize strong metrics, and visibility of the offerings to target audience. Our motto is to help clients with all decision making process, deliverables, and challenges.
  • Aarkstore adds value to business by providing custom market research on integrated solutions, and branding.
  • The custom reports operate in service offerings, market share, operational strength, distributors, clientele, products employees, patents, and more.

Custom Reports Handle Core Consulting Facilities

We cover all the prime types of consumer research available in reports: market sizing, historic and forecast data, regional country data, market segments, customer information, supplier information, market characteristics and trends, custom reports, regulatory information, financial analysis, company analysis and market shares. We offer market research online database service.

  • Management of portal, arranging interviews, and employing top market research companies.
  • SWOT analysis, risk management, benchmarking and competitive landscaping.
  • Forecasts of economics, industry specific systems and technologies.
  • Timely delivery of custom market research at any point of crisis or opportunity.
  • Defining unmet needs of customers or business, and stating key buying criteria.

Understanding User and Business Perspective

We orient strategies on basis on how users view different competitors and vendors for various buying possibilities. Aarkstore pitches marketing research that uses comments and inputs from actual audience, and interacts with competitors for secondary intelligence. We offer support custom reports from popular publishers for functional, technical, pricing, business models, premiums, planning, distribution, focus areas, customer targets, investments, geographic spread, and others.

  • Aarkstore delves in white paper study for B2B and B2C level, and follow a top down approach for knowing the challenges.
  • The consumer research analyses demand and supply ratios and mapping of value chain against they purchases.
  • We associate with market research companies for technology reports to draw a roadmap for client’s success.

Serving Specific Requirements of Clients

Our pioneering analyses are to satisfy the business professionals and match up with user requirements. Well researched documents are clubbed in our market research online files, which clients can refer at ease, if they want to. We often develop a straightforward strategy with custom market research that places business amidst top of competitors, and schedule a path to directed goals, as swiftly as we can.

  • The business research reports are comparative to deep study of each and every specific of clients and users, and then a planning model is executed.
  • The client is given a 360 degree view of the treats from the market, industry, competitors, government regulations, new trends, and provides marketing research benefits.
  • We station reserve a bounty of business ideas, and a plan B in case the client wishes a change in plans, our research support will be there to jump to course of action.

Health and Beauty Retailing in Poland – Market Summary and Forecasts; Comprehensive overview of the market, consumer, and competitive context, with retail sales value and forecasts to 2020

Health and Beauty

Synopsis
“Health and Beauty Retailing in Poland – Market Summary and Forecasts” is a detailed sector report providing a comprehensive analysis of the emerging trends, forecasts and opportunities to 2020.

What else does this report offer?

– A thorough analysis of consumer trends changing economic and population factors

– Both qualitative and quantitative insights and analysis of the shifting health and beauty retail dynamics from 2010 to 2020

– Sales of health and beauty products through the following channels from 2010 to 2020: Hypermarkets, supermarkets and hard-discounters; department stores; online; drug stores and health and beauty stores; other general and non-specialist direct retailers; cash and carries and warehouse clubs; convenience stores (including independents) and gas stations; duty free retailers; value, variety stores, general merchandise retailers and vending machines

– An overview of key health and beauty retailers operating across Poland and their presence across distribution channels

Summary
The retail market for health and beauty products in Poland reached PLN19.7 billion in 2015 and is forecast to grow at a CAGR of 4.4% during 2015-2020, to reach PLN24.5 billion by 2020. Sturdy economic conditions, urbanization, increasing health consciousness, and an increasing aging population have fueled the growth of the health and beauty category.

Key Findings
– Online spending on health and beauty products accounts for 2.8% of the total retail sales in the segment in 2015

– The health and beauty segment accounted for 3.84% of the overall retail sales in 2015

– Specialist retailers continue to be the preferred channel for the purchase of health and beauty products in the country.

– Bulk sales of health and beauty products are carried through offline channels including hypermarkets, supermarkets, department stores, drug stores and health and beauty stores.

Browse full report @ http://www.aarkstore.com/healthcare/210357/health-and-beauty-retailing-in-poland-market-summary-and-forecasts-comprehensive-overview-of-the-market-consumer-and-competitive-context-with-retail-sales-value-and-forecasts-to-2020

Reasons To Buy
– Gain a comprehensive knowledge on health and beauty sector in the Poland retail market and develop a competitive advantage from the start of your supply chain

– Investigate current and forecast behaviour trends in health and beauty category to identify the best opportunities to exploit

– Analyze the recommended actions to align your marketing strategies with the crucial trends influencing the consumer behavior

– Understand the performance of health and beauty product sector, with insights on performance across key channels from 2010, with forecasts until 2020

– Explore novel opportunities that will allow you to align your product offerings and strategies to meet demand by analyzing the vital economic and population trends, key consumer and technology trends influencing the health and beauty market

– Analysis of key international and domestic players operating in the health and beauty market – including store counts and revenues that give you a competitive edge – identify opportunities to improve your market share.

Best Selling Reports :

GlaxoSmithKline Biologicals S.A. – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Health and Beauty Retailing in China – Market Summary and Forecasts; Comprehensive overview of the market, consumer, and competitive context, with retail sales value and forecasts to 2020

 

W.O.M. World Of Medicine GmbH – Strategic SWOT Analysis Review

Summary

W.O.M. World Of Medicine GmbH – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – GlobalData’s summarization of the company’s business strategy.
– SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.

Browse full report @ http://www.aarkstore.com/medical-devices/210185/wom-world-of-medicine-gmbh-strategic-swot-analysis-review

Highlights

W.O.M. World of Medicine GmbH (WOM), a subsidiary of ATON GmbH, develops, manufactures, and supplies minimally invasive medical equipment to original equipment manufacturers (OEM). The product portfolio of the company encompasses cameras and photonics; insufflators and pumps; cardiac-thoracic instruments; and disposables. It offers contract manufacturing services for medical products and precision parts and assemblies. WOM also offers technical services; as well as assists in filing return merchandise authorization application for product returns and implementation of unique device identification requirements. The company sells its products through authorized distributors in the world. The company has production facilities in Ludwigsstadt and Reichenbach. It operates in Orlando, the US, and Quarry Bay, Hong Kong. WOM is headquartered in Berlin, Germany.

Reasons to Buy

– Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
– Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
– Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
– Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Best Selling Reports :

Baylor College of Medicine – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Albert Einstein College of Medicine – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook

gene therapySummary

“Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook”” discusses all gene therapies under the broad criteria of genetic material introduced to the cell for a therapeutic purpose. It includes not only the insertion of a gene into the cell for expression, but also gene silencing with RNA interference (RNAi) and antisense RNA, aptamers (DNA or RNA polymers which bind to a protein target), and oncolytic viruses.

Gene therapies have been in development in humans for 25 years, and a number of products have begun to enter the pharmaceutical market. However, due to various challenges and clinical trial setbacks, progress in developing this technology and achieving suitability for commercial usage has been slow. Gene therapies only account for a marginal market share and many efficacy and safety concerns remain unaddressed. However, the pipeline is robust; 906 pipeline gene therapies are currently in development. Most are at an early stage of development, with 76% at the Discovery or Preclinical stage. However, there are currently 23 gene therapy programs in Phase III development and two at the Pre-registration stage. This indicates that although gene therapies are beginning to reach the market after two decades of research in humans, the majority remain in relatively early development.

This CBR report provides a comprehensive view of the clinical, R&D, commercial and competitive landscape of Gene Therapy, and assesses key developments in delivery vector technology, and challenges and advances associated with the production of such vectors.

Scope

Despite 25 years of clinical research, only a few gene therapies of all types have reached the market globally, and none have achieved strong clinical or commercial success –
– Why do gene therapies still occupy only a minimal market share in their respective indications?
– What can be learned from the gene therapies that have already reached the market?
A number of different viral and non-viral vector types are currently in development for the delivery of gene therapies –
– What are the relative advantages and disadvantages of each vector type and which hold the most promise?
– What proportion of the overall gene therapy R&D pipeline is occupied by each vector type?
The current pipeline for gene therapies is diverse in terms of the approaches and vectors covered; 50% are gene silencing therapies, while 31% involve the insertion of a functional gene –
– In which therapy areas is there the highest level of R&D activity for gene therapies?
– At which stage of development does the majority of pipeline gene therapies reside?
– What is the proportion of the pipeline occupied by each intervention and vector type overall?
A number of companies are currently actively developing pipeline gene therapies, including private, public and institutional enterprises –
– How do gene therapies fit into the overall portfolios of these companies?
– What is the level of involvement in gene therapy research from the top 20 Big Pharma companies?

Browse full report @ http://www.aarkstore.com/pharmaceuticals-healthcare/149996/gene-therapies-a-diverse-range-of-technologies-with-a-promising-long-term-outlook

Key Reasons to Purchase

-Understand the current status of the field of therapeutic gene therapies, and the relative clinical and commercial success of currently marketed products, comprising Glybera, Kynamro, Macugen, Vitravene, Gendicine, Oncorine, and Neovasculgen.
– Assess the pipeline for gene therapies split by therapy area, vector type and intervention type, and stage of development. Additionally, a granular assessment of the pipeline is provided across the four major therapy areas for gene therapy: oncology, infectious diseases, central nervous system disorders, and genetic disorders.
– Gain a picture of the current competitive landscape, with a detailed breakdown of companies actively involved in the gene therapy pipeline. Understand the level of involvement on the part of big pharma companies, and the extent to which gene therapies fit into the overall portfolios of companies in this field. Additionally, a highly granular breakdown of companies developing multiple gene therapies is provided.

Best Selling Reports :

EnGeneIC Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Frontier Pharma: Schizophrenia and Associated Indications – Small but Diverse Range of First-in-Class Molecular Targets Hold Promise for Treatment of Negative and Cognitive Symptoms

 

Edwards Lifesciences Corporation (EW) – Financial and Strategic SWOT Analysis Review

Summary

Edwards Lifesciences Corporation (EW) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Highlights

Edwards Lifesciences Corporation (Edwards) operates in the heart valves and hemodynamic monitoring industry. The company develops, manufactures and markets products and technologies used for the treatment of structural heart disease and critically ill patients. It develops and commercializes heart valve products such as tissue heart valves and repair products, which are used for the replacement of repairing of a patients diseased or defective heart valve. Edwards also offers hemodynamic monitoring systems, which is used for the measurement of a patients cardiovascular function in the hospital setting. The company operates across the US, Europe, Japan and rest of world.

Browse full report @ http://www.aarkstore.com/general-medical-devices/176542/edwards-lifesciences-corporation-ew-financial-and-strategic-swot-analysis-review

The profile contains critical company information including:

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Best Selling Reports :

Edwards Lifesciences Corporation (EW) – Medical Equipment – Deals and Alliances Profile

Edwards Lifesciences Corporation (EW) – Product Pipeline Analysis, 2016 Update

Arqiva Broadcast Holdings Limited: Media – Company Profile and SWOT Analysis

Synopsis

Arqiva Broadcast Holdings Limited (Arqiva) owns and operates communications infrastructure. The company is involved in providing television and radio transmission and communication, and media services. Arqiva provides cellular, wireless broadband, voice and data solutions for network operators and governments, apart from providing critical communications infrastructure for local government and public safety organizations. The company provides communication platforms to enterprise, government agencies and broadcast customers across the world. Arqiva owns and operates two commercial digital terrestrial TV multiplexes and two HD multiplexes, which provide broadcasters with access to the UKs Free view DTT platform. Arqiva is headquartered in Winchester, the UK.

– This business intelligence report presents the key company information, essential to understanding industry challenges and competitors.

– The SWOT analysis identifies the companys strengths, weaknesses, opportunities for growth and threats. The key competitors are dissected alongside the larger challenges that the industry is facing.

– The company profile relays all current information about the business operations, including key employees, major products and services, company history, locations and subsidiaries alongside a supporting statement from the Chairman and Managing Director.

Summary

ICD Researchs “”Arqiva Broadcast Holdings Limited: Media – Company Profile and SWOT Analysis”” contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, recent developments, key employees as well as company locations and subsidiaries.

Browse full report @ http://www.aarkstore.com/swot-analysis/210231/arqiva-broadcast-holdings-limited-media-company-profile-and-swot-analysis

Key Highlights

Arqiva Broadcast Holdings Limited (Arqiva) owns and operates communications infrastructure. The company is involved in providing television and radio transmission and communication, and media services. Arqiva provides cellular, wireless broadband, voice and data solutions for network operators and governments, apart from providing critical communications infrastructure for local government and public safety organizations. The company provides communication platforms to enterprise, government agencies and broadcast customers across the world. Arqiva owns and operates two commercial digital terrestrial TV multiplexes and two HD multiplexes, which provide broadcasters with access to the UKs Free view DTT platform. Arqiva is headquartered in Winchester, the UK.

Reasons To Buy

– Quickly enhance your understanding of “”Arqiva Broadcast Holdings Limited””

– Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.

– Increase business/sales activities by understanding your competitors businesses better.

– Recognize potential partnerships and suppliers.

Key Findings

This report is a crucial resource for industry executives and anyone looking to access key information about “”Arqiva Broadcast Holdings Limited””

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Best Selling Reports :

Gordon Ramsay Holdings Limited: Foodservice – Company Profile and SWOT Analysis

CG Restaurants and Bars Holdings Limited: Foodservice – Company Profile and SWOT Analysis

%d bloggers like this: